Bridging the gap – estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel

During the first two pandemic years, Germany lacked rapid adaptive population-based panels for epidemic diseases [1] as well as the capacity for central modelling platforms to quickly integrate information from cross-sectional surveys [2-4]. Instead, several population-specific and population-based seroprevalence studies were performed, and the results not published fast enough and rarely used in model estimates or scenarios [5]. Modelling groups operated independently without a central platform for harmonization and integration of results [6].
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research